VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹395 Cr | ₹397 Cr | ₹360 Cr | ₹323 Cr | ₹278 Cr |
What is the latest Total Current Assets ratio of VENUS REMEDIES ?
| Year | Total Current Assets |
|---|---|
| Mar2026 | ₹395 Cr |
| Mar2025 | ₹397 Cr |
| Mar2024 | ₹360 Cr |
| Mar2023 | ₹323 Cr |
| Mar2022 | ₹278 Cr |
How is Total Current Assets of VENUS REMEDIES Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹395 Cr | -0.43 | |
| Mar2025 | ₹397 Cr | 10.40 | |
| Mar2024 | ₹360 Cr | 11.36 | |
| Mar2023 | ₹323 Cr | 16.11 | |
| Mar2022 | ₹278 Cr | - | |
Compare Total Current Assets of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,650.5 Cr | -15.4% | -28% | 190.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -15.4% |
-28% |
190.6% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses